PROS1 and COVID-19: The Beta variant caused reinfection for patients infected with COVID-19, and also contributed to infection among healthy subjects who were inoculated with the first dose of ChAdOx1 vaccine, a recombinant adenoviral vector targeting the S protein of SARS-CoV-2, in Dhaka, Bangladesh (54).